Health AI Central
Peer-Reviewed Publication
Am Health Drug Benefits2015;8(5):263-71.January 1, 2015Journal Article

Value-Based Benefit Design to Improve Medication Adherence for Employees with Anxiety or Depression.

Kimberly J Reid1, Kathleen M Aguilar2, Eric Thompson3, Ross M Miller4
1Biostatistician, Cerner Population Health Services, Kansas City, MO.
2Scientist, Cerner Research Services, Culver City, CA.
3Director of Business Intelligence and Analytics, KaMMCO Health Solutions, Topeka, KS, and Senior Financial Analyst II, Children's Mercy Hospital, Topeka, KS.
4Medical Director, Population Health Services, Cerner Health Connections, Culver City, CA.
PubMed PMC PDF

Abstract

BACKGROUND: Through reduced out-of-pocket costs and wellness offerings, value-based benefit design (VBBD) is a promising strategy to improve medication adherence and other health-related outcomes across populations. There is limited evidence, however, of the effectiveness of these policy-level changes among individuals with anxiety or depression. OBJECTIVES: To assess the impact of a multifaceted…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Create Free AccountSign In

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.